Product/Composition:- | Mebeverine Tablets and capsules |
---|---|
Strength:- | 135 mg tablets and 200 mg Capsules |
Form:- | Tablets and capsules |
Reference Brands:- | Duspatalin(EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Mebeverine tablets and capsules are antispasmodics that relax intestinal muscles by inhibiting calcium ions, reducing spasms and cramping. They effectively relieve IBS symptoms, improve bowel function, and decrease abdominal pain. Benefits include symptom relief, enhanced comfort, and improved quality of life for patients with intestinal motility disorders
Mebeverine tablets and capsules, marketed as Duspatalin, are approved in the EU and available as generics. In the US, they are sold as OTC or prescription-only in some formulations. Regulatory approval requires dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the EU, EMA guidelines oversee safety and quality, while in the US, FDA regulations apply. For dossier preparation, regulatory pathways, and market access strategies, visit PharmaTradz. Ensuring compliance supports timely approval, safe use, and worldwide availability, aiding patients with irritable bowel syndrome and intestinal spasms across regions.